Vedolizumab New

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP26256CAS No. ：943609-66-3Purity：98%

Get Quotation Now

Tel: 0086-13026320035 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	943609-66-3	Cat. No.	BCP26256
Name	Vedolizumab
Synonyms	MLN-02; LDP-02; MLN0002;Anti-Human lymphocyte α4β7 integrin, Humanized Antibody;
SMILES
Chemical Name
Formula	C6528H10072N1732O2042S42	M. Wt	146834.53
Purity	98%	Storage	Store at 4-8°C
Description	Vedolizumab is a monoclonal antibody binds to integrin α4β7. Vedolizumab blocks the α4β7 integrin, results in gut-selective anti-inflammatory activity. Vedolizumab binds to memory CD4(+) T and B lymphocytes with subnanomolar potency (EC(50) = 0.3-0.4 nM). Vedolizumab also binds to eosinophils at high levels, and to naive T-helper lymphocytes, naive and memory cytotoxic T lymphocytes, B lymphocytes, natural killer cells, and basophils at lower levels. Vedolizumab selectively inhibits adhesion of alpha(4)beta(7)-expressing cells to mucosal addressin cell adhesion molecule 1 (median inhibition concentration [IC(50)] = 0.02-0.06 microg/ml) and fibronectin (IC(50) = 0.02 microg/ml), but not vascular cell adhesion molecule.